BioCentury
ARTICLE | Company News

Aspen, Sigma Pharmaceuticals Ltd. deal

August 23, 2010 7:00 AM UTC

Aspen will acquire Sigma's pharmaceuticals division for A$900 million ($800.5 million) in cash. The division, which includes Sigma's over-the-counter (OTC) and generic products, had sales of A$671 mil...